Nectar Lifesciences Limited

BSE:NECLIFE.BO

$38.16 INR

-$0.06 (-0.16%)

Volume
7.53K
Average Volume
237.69K
Market Capitalization
$8.56B
P/E Ratio
106.24
Dividend Yield
0.00%
Price Target
$
Year High
$45.70
Year Low
$14.36
Payout Ratio
$0.00
Current Ratio
$0.00

Industry, Sector & symbol

Stock Exchange Bombay Stock Exchange
CEO Mr. Amit Chadah
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
Current Symbol NECLIFE.BO
CUSIP None
CIK None
Web https://www.neclife.com
Phone 91 17 2304 7777
Currency INR
Employees 1589
Country IN

Liquidity

Debt-to-Equity Ratio 0.00
Payout Ratio 0.00
Current Ratio 0.00
Quick Ratio 0.00
Cash Ratio 0.00

Sales & Book Value

Annual Sales $15.24B
Price / Sales 0.52
Cash Flow 1.66
Price / Cash Flow 22.97
Price / Book 0.00

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Neutral
Rating Score(0-5) 3
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-1.08
Trailing P/E Ratio 106.24
PEG Ratio -0.54
P/E Growth -0.54
Net Income $-241.83M
Net Margin 0.49%
Pretax Margin 0.53%
Return on Equity 1.51%
Return on Assets 0.00%

Financials Score

AltmanZ Score
Piotroski Score 6.00
Working Capital -
Total Assets -
Ebit 540.69M
Market Cap 8.56B
Total Liabilities -

Poll Results

About Nectar Lifesciences Limited (BSE:NECLIFE.BO) Stock

Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and mint derivatives and empty hard gelatin capsules. Nectar Lifesciences Limited was incorporated in 1995 and is head ... quartered in Chandigarh, India.

Frequently Asked Questions

What is the current Nectar Lifesciences Limited (NECLIFE.BO) stock price?

Nectar Lifesciences Limited(BSE:NECLIFE.BO) stock price is $38.16 in the last trading session. During the trading session, NECLIFE.BO stock reached the peak price of $45.7 while $14.36 was the lowest point it dropped to. The percentage change in NECLIFE.BO stock occurred in the recent session was --0.16% while the dollar amount for the price change in NECLIFE.BO stock was -$-0.06.

NECLIFE.BO's industry and sector of operation?

The BSE listed NECLIFE.BO is part of Drug Manufacturers—Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of NECLIFE.BO?

Mr. Sanjiv Goyal | Chairman & MD
Ms. Neha Vaishnav | Company Secretary & Compliance Officer
Mr. Puneet Sud B.Tech. | Director of Operations & Wholetime Director
Mr. Amit Chadah | Chief Executive Officer
Mr. Sushil Kapoor | Chief Financial Officer

How many employees does NECLIFE.BO have?

Number of NECLIFE.BO employees currently stands at 1589. NECLIFE.BO operates from SCO 38-39, Chandigarh, None 160009, IN.

Link for NECLIFE.BO official website?

Official Website of NECLIFE.BO is: https://www.neclife.com

How do I contact NECLIFE.BO?

NECLIFE.BO could be contacted at phone #91 17 2304 7777 and can also be accessed through its website. NECLIFE.BO operates from SCO 38-39, Chandigarh, None 160009, IN.

How many shares of NECLIFE.BO are traded daily?

The average number of NECLIFE.BO shares traded daily for last 3 months was 237.69K.

What is the market cap of NECLIFE.BO currently?

The market value of NECLIFE.BO currently stands at $8.56B with its latest stock price at $38.16